Cellectis receives the 2009 INPI National Innovation Award
The awards, organized annually by the INPI since 1991, honor small and mediumsized companies whose growth can be attributed to their outstanding innovation policies and which use a comprehensive intellectual property (IP) strategy to leverage business growth: economic intelligence, technology watching, IP rights (including patents, trademarks, registered designs and registered models), managing and exploiting license agreements, and combating infringement. After a regional competition, a panel of judges selects the national award winners.
“2009 was a very busy year for Cellectis in terms of IP,” said Cellectis CEO André Choulika. “We filed 15 new patent applications and had four patents granted. We also acquired the Vectocell® technology which has added an additional nine new patent families to our portfolio,” he added.
To date, Cellectis holds a portfolio of 58 granted patents for a total of more than 260 patents and patent applications.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.